دورية أكاديمية

HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答

التفاصيل البيبلوغرافية
العنوان: HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
المؤلفون: Neihenuo Chuzho, Neetu Mishra, Nikhil Tandon, Uma Kanga, Gunja Mishra, Akanksha Sharma, Narinder K. Mehra, Neeraj Kumar
المصدر: Journal of Diabetes, Vol 15, Iss 7, Pp 607-621 (2023)
بيانات النشر: Wiley, 2023.
سنة النشر: 2023
المجموعة: LCC:Diseases of the endocrine glands. Clinical endocrinology
مصطلحات موضوعية: CD4 T细胞, 细胞因子, GAD65, HLA, 1型糖尿病, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
الوصف: Abstract Aim We planned this study to identify diabetogenic glutamic acid decarboxylase (GAD65) peptides possibly responsible for human leucocyte antigen (HLA)‐DR3/DQ2‐mediated activation of GAD65‐specific CD4 T cells in type 1 diabetes (T1D). Methods Top 30 GAD65 peptides, found to strongly bind in silico with HLA‐DR3/DQ2 molecules, were selected and grouped into four pools. The peptides were used to stimulate CD4 T cells of study subjects in 16‐h peripheral blood mononuclear cell culture. CD4 T cells' stimulation in terms of interferon‐gamma (IFN‐γ), interleukin (IL)‐17, tumor necrosis factor‐alpha (TNF‐α), and IL‐10 expression was analyzed using flow cytometry. Results Although all four GAD65 peptide pools (PP1‐4) resulted in significantly higher expression of IFN‐γ by CD4 T cells (p = .003, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1753-0407
1753-0393
العلاقة: https://doaj.org/toc/1753-0393Test; https://doaj.org/toc/1753-0407Test
DOI: 10.1111/1753-0407.13406
الوصول الحر: https://doaj.org/article/29ef37f916e442c4abfe137d2e417e0cTest
رقم الانضمام: edsdoj.29ef37f916e442c4abfe137d2e417e0c
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:17530407
17530393
DOI:10.1111/1753-0407.13406